最少侵入性的中枢门修复使用跨导管管弦附加物
Chandan Das1, Ghayth Al Awwa1, Emmanuel L Mills2
1Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Mail Code L353, Portland, OR 97239, USA.
Interventional cardiology clinics
|March 3, 2024
概括
通过导管的 mitralia 带置换为 mitralia 吐 (MR) 提供了一个不那么侵入性的选择. 这种技术使用人造来恢复传单功能,在早期研究中显示出有前途的安全性和有效性.
科学领域:
- 干预心脏病学 干预心脏病学
- 生物医学工程 生物医学工程
- 心脏外科手术 心脏外科手术
背景情况:
- 手术修复 mitra 门是对 mitra 反 (MR) 的传统治疗方法.
- 过导管技术为特定患者群体提供了不那么侵入性的替代方案.
- 退行性 mitra 膜疾病通常涉及延长或破裂的 chordae tendineae.
研究的目的:
- 为了评估跨导管 mitra 带置换的安全性和有效性.
- 评估对MR的最小侵入性方法的潜力.
- 为了确定对叶片共和吐严重性的影响.
主要方法:
- 通过导管输送人造.
- 定人造的chordae到双肩叶片和乳头肌肉或心室顶部.
- 评估程序成功,安全终点和血液动力学参数.
主要成果:
- 证明了成功地植入人造鱼.
- 观察到 mitra 反症的严重性减少.
- 早期研究表明有前途的安全性和症状改善.
结论:
- 透导管 mitra 带置换是一种可行的,对MR的侵入性较小的选择.
- 这项技术恢复了叶片的合并,并减少了吐.
- 需要进一步的研究和试验来证实长期的结果.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


